Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: A cohort study from Cambodia

BMC Pediatrics

Volumn 9, Issue , 2009, Pages 54-

  Raguenaud, Marie Eve ^a   Isaakidis, Petros ^a   Zachariah, Rony ^b   Te, Vantha ^c   Soeung, Seithabot ^d   Akao, Kazumi ^d   Kumar, Varun ^d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c Donkeo Referral Hospital   (Cambodia)

^d Angkor Hospital for Children   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; CAMBODIA; CAUSE OF DEATH; CHILD; CHILD DEATH; CHILDHOOD MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 70349859655     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-9-54     Document Type: Article

References (15)

1. Sutcliffe CG, van Kijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008, 8:477-89. 10.1016/S1473-3099(08)70180-4, 18652994.
2. Janssens B, Raleigh B, Soeung S, Akao K, Te V, Gupta J, Vun MC, Ford N, Nouhin J, Nerrienet E. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007, 120:1134-1134.
3. Kumarasamy N, Venkatesh KK, Devaleenol B, Poongulali S, Mothi SN, Solomon S. Safety, Tolerability and Effectiveness of Generic HAART in HIV-Infected Children in South India. J Trop Pediatr 2009, 55(3):155-159. 10.1093/tropej/fmn080, 18829638.
4. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Lutalo T, Nalugoda F, Sewankambo N, Kiduggavu M, Wawer M, Gray R. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006, 41(4):504-8. 10.1097/01.qai.0000188122.15493.0a, 16652060.
5. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F, . Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364(9441):1236-43. 10.1016/S0140-6736(04)17140-7, 15464184.
6. Center for Disease Control 1994 Revised classification system for HIV infection in children <13 years old. MMWR Morb Mortal Wkly Rep 1987, 43(RR-12):1-10.
7. World Health Organization Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach, 2003 Revision. 2004, Geneva, Switzerland: World Health Organization.
8. World Health Organization Antiretroviral Therapy of HIV infection in infants and children in resource-limited settings: towards universal access. 2006, Geneva, Switzerland: World Health Organization.
9. Sutcliffe CG, Scott S, Mugala N, Ndhlovu Z, Monze M, Quinn TC, Cousens S, Griffin DE, Moss WJ. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. CID 2008, 47:837-44.
10. Walker AS, Mulenga V, Ford D, Kabamba D, Sinyinza F, Kankasa C, Chintu C, Gibb DM, . CHAP Team The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clin Infect Dis 2007, 44(10):1361-7. 10.1086/515396, 17443476.
11. WHO report 2009 - Global Tuberculosis Control : Cambodia profile. WHO website 93-96. WHO, Accessed November 20, 2008., http://www.who.int/tb/publications/global_report/2009/pdf/khm.pdf
12. World Health Organization TB/HIV A clinical Manual. 2004, Geneva, Switzerland: World Health Organization.
13. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004, 18:887-895. 10.1097/00002030-200404090-00006, 15060436.
14. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA, . CHER Study Team Early Antiretroviral Therapy and Mortality among HIV-Infected Infants. N Engl J Med 2008, 359:2233-44. 10.1056/NEJMoa0800971, 19020325.
15. Report of the WHO Technical Reference Group, Pediatric HIV/ART Care Guideline Group Meeting WHO Antiretroviral Therapy for Infants and Children 2008 WHO Headquarters, Geneva, Switzerland 10-11 April 2008.